Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

The aim of the present clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases is to review the current knowledge on the epidemiology, pathogenesis, diagnosis, therapy, and outcomes of myocardial and pericardial complications of coronavirus disease 2019 (COVID-19) and vaccination in order to improve the awareness and clinical confidence on the management of patients with these complications. The risk of myopericardial complications is especially higher within 1 month of COVID-19 disease and vaccination. Forms related to the disease are generally more common and severe than those related to vaccination. Even if vaccination against COVID-19 increases myocarditis risk, this risk is lower in vaccinated than non-vaccinated COVID-19 individuals, supporting the vaccine use. Overall, COVID-19 related complications, especially myocarditis, are relatively rare.

Authors

Institutions

Publication Details

Journal
European Heart Journal
Published
2025-05-20
DOI
https://doi.org/10.1093/eurheartj/ehaf222
Citations
8
Primary Topic
Viral Infections and Immunology Research
Type
article
Field-Weighted Citation Impact
11.11
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Angelos G. Rigopoulos, Antonio Luca Brucato, Mary N. Sheppard, R Marcolongo et al.
8 citations
European Heart Journal
Viral Infections and Immunology Research
11.11
article

Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Angelos G. Rigopoulos, Antonio Luca Brucato, Mary N. Sheppard, R Marcolongo, Lia Crotti, Antonios Pantazis, Gianfranco Sinagra, Lorenzo Dagna, George A. Lazaros, Allan L. Klein, Karin Klingel, Massimo Imazio, Alida L.P. Caforio, Silvia Castelletti, Petr Kuchynka, Yehuda Adler, Andrea Frustaci, Petar Seferović, Cristina Basso, Marco Merlo, Arsen Ristić, Chiara Bucciarelli‐Ducci, Matteo Cameli, Carsten Tschöpe, Johanna Kuusisto, A Lopez Sainz, Thomas F. Lüscher
article en
8 citations

Abstract

The aim of the present clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases is to review the current knowledge on the epidemiology, pathogenesis, diagnosis, therapy, and outcomes of myocardial and pericardial complications of coronavirus disease 2019 (COVID-19) and vaccination in order to improve the awareness and clinical confidence on the management of patients with these complications. The risk of myopericardial complications is especially higher within 1 month of COVID-19 disease and vaccination. Forms related to the disease are generally more common and severe than those related to vaccination. Even if vaccination against COVID-19 increases myocarditis risk, this risk is lower in vaccinated than non-vaccinated COVID-19 individuals, supporting the vaccine use. Overall, COVID-19 related complications, especially myocarditis, are relatively rare.

European Heart JournalVol. 46(34)
University of Siena (IT), University of Udine (IT), Cleveland Clinic (US), Serbian Academy of Sciences and Arts (RS), University of Padua (IT), University of Trieste (IT), Vita-Salute San Raffaele University (IT), Tel Aviv University (IL), St George's, University of London (GB), University of Milan (IT), Guy's and St Thomas' NHS Foundation Trust (GB), University of Zurich (CH), Charles University (CZ), Royal Brompton & Harefield NHS Foundation Trust (GB), Harefield Hospital (GB), University of Belgrade (RS), Kuopio University Hospital (FI), Royal Brompton Hospital (GB), Lung Institute (US), National Heart Hospital (BG), Hospital Clínic de Barcelona (ES), University Children's Hospital Tübingen (DE), Ospedale Santa Maria della Misericordia di Udine (IT), Berlin-Brandenburger Centrum für Regenerative Therapien (DE), German Centre for Cardiovascular Research (DE), Mitera Hospital (GR), Royal Hospital (OM), IRCCS Istituto Auxologico Italiano (IT), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Deutsches Herzzentrum München (DE), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Azienda Sanitaria Universitaria Integrata di Trieste (IT), Hippocration General Hospital (GR), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), City St George's, University of London (GB), Imperial College London (GB), University of Milano-Bicocca (IT), Misericordia University (US), Charité - Universitätsmedizin Berlin (DE), University of Tübingen (DE)
Good health and well-being
Openalex Percentile: Top 1%
Viral Infections and Immunology Research
11.11
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.